Skip to content

S1R Imaging-Based Cryoneurolysis in Chronic Pain

Not yet recruitingEarly phase 1NCT07768501
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The goal of this clinical trial is to determine whether a sigma-1 receptor PET/MRI scan can help identify the specific nerves responsible for chronic pain. Researchers will use an investigational imaging agent called \[18F\]FTC-146 to look for signs of pain generating nerve irritation or injury that may not be visible on convention imaging tests. Participants whose pain-generating nerve can be identified may undergo a diagnostic nerve block and, if successful, a standard clinical procedure called cryoneurolysis will be used to temporarily interrupt pain signals.

Study details

Official title
Molecular Imaging-Based Cryoneurolysis: Targeting Upregulated Sigma-1 Receptor Positive Nerves in Chronic Pain
Conditions
Interventions
  • Drug: [18F]-FTC-146
Sponsor
Davidzon, Guido, M.D.
Collaborators
Society of Interventional Radiology Foundation
Organization
Stanford University
Start date
2026-09
Primary completion
2029-09
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Chronic nociceptive, neuropathic, or mixed pain for ≥2 months 2. Pain originating from a region amenable to cryoneurolysis (celiac plexus, intercostal nerves, pudendal nerve, peripheral nerve block 3. Chronic pain ≥2 months 4. Pain score ≥4/10 5. Pain location amenable to cryoneurolysis 6. Willing and able to provide consent. Exclusion Criteria: 1. Pregnancy or nursing. 2. Non-English speaking individuals 3. Contraindication to MRI scanning which includes, but is not limited to, incompatible metal or hardware including pacemakers, cochlear implants, and bullets near a critical organ. 4. Weight \>350 pounds or a large body habitus, which the MR scanner cannot accommodate. 5. Claustrophobia or feeling that he or she will be unable to lie still in the scanner for a period of 2 hours or fit in the PET/MR scanner due to body size.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07768501